Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval.
- 1 June 1985
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 82 (12) , 4147-4151
- https://doi.org/10.1073/pnas.82.12.4147
Abstract
Type beta transforming growth factor/growth inhibitor (TGF-beta/GI) is demonstrated to be a potent stimulator of DNA synthesis in AKR-2B mouse embryo cells with a prolonged (greater than 24 hr) prereplicative phase when compared with other growth factors (epidermal growth factor, platelet-derived growth factor, or fibroblast growth factor) that induce DNA synthesis 12-14 hr after stimulation. In addition, TGF-beta/GI inhibits the early peak of DNA synthesis produced by EGF and insulin before the later stimulatory effects of TGF-beta/GI become manifest. TGF-beta/GI induces a marked morphologic transformation in these cells prior to their entry into S phase. Like the other growth factors, TGF-beta/GI stimulates an early increase in the rate of protein synthesis in AKR-2B cells and its stimulatory effect on DNA synthesis is enhanced by insulin. The data show that this molecule is a growth factor for certain mesenchymal cells in monolayer culture but only after a prereplicative phase that is significantly longer than that of other growth factors.This publication has 23 references indexed in Scilit:
- Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human platelets.Proceedings of the National Academy of Sciences, 1984
- Transforming growth factor-β controls receptor levels for epidermal growth factor in NRK fibroblastsCell, 1984
- Purification and properties of a type .beta. transforming growth factor from bovine kidneyBiochemistry, 1983
- Purification and initial characterization of a type beta transforming growth factor from human placenta.Proceedings of the National Academy of Sciences, 1983
- Serum contains a platelet-derived transforming growth factor.Proceedings of the National Academy of Sciences, 1982
- Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cellsExperimental Cell Research, 1982
- Mouse embryos contain polypeptide growth factor(s) capable of inducing a reversible neoplastic phenotype in nontransformed cells in cultureJournal of Cellular Physiology, 1982
- Improved medium and culture conditions for clonal growth with minimal serum protein and for enhanced serum-free survival of Swiss 3T3 cellsIn Vitro Cellular & Developmental Biology - Plant, 1981
- Gene expression in chemically transformed mouse embryo cells: Selective enhancement of the expression of C type RNA tumor virus genesCell, 1977
- Effect of cell proliferation on levels and diversity of poly(A)-containing mRNACell, 1976